My opinion is Gale will prevail. Analysts have not changed their opinions and the only thing I noticed any different was the target price fell .25 cents to $6.00. Tells me things are still mighty fine. Still think Nuevax will be a life changer for breast cancer. I'm all in for the long haul no matter what till Nuevax proves me wrong.